HIV Testing

Roche, Qiagen to develop diagnostic system for hepatitis and HIV PCR testing

Published in AIDS Weekly, June 17th, 2002

Roche Molecular Systems, Inc., (RMS), a business area of Roche Diagnostics and Roche Diagnostics Corp. (RDC), the U.S. sales and marketing arm of Roche Diagnostics, and Qiagen GmbH, a wholly owned subsidiary of Qiagen N.V. (QGENF) announced that they have entered into a development, manufacturing, and supply agreement.

This partnership has the goal of developing and distributing a customized integrated diagnostic system for use in the nucleic acid sample preparation, detection and quantification of the hepatitis B, hepatitis C and human immunodeficiency (HIV-1) viruses based on Roche's patented polymerase chain reaction (PCR) technology.

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2002-06-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry